Indoor residual sprayings
DeviceHouses will be spayed with this formulation containing Pyrimiphos methyl.
Other names: Actellic
NCT Number: NCT03074435
This study evaluates the benefit to use 1) insecticide residual sprayings, 2) larvicides, 3) Ivermectin for domestic animals and 4) behaviour change communication strategy to complement the universal coverage with LLINs through a cluster randomized trial.
Looking for future studies?
Notify MeUp to 21 year
All sexes
Interventional
Phase 3
Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
For Cross-sectional surveys only, maximum age for participating in the study was 21 y/o in Côte d Ivoire and 18 y/o in Burkina Faso.
Houses will be spayed with this formulation containing Pyrimiphos methyl.
Other names: Actellic
Larval breeding sites will be treated with larvicide
Time frame: continuous monitoring during 2 years
Malaria cases (whole population, every ages) registered in the local health system.
Time frame: Every 8 weeks during 2 years
Number of infectious bites/personn
Time frame: Every 4 months during 2 years
% of positive blood smears among the 0-18 y/o population as recorded during cross sectional surveys.
Institut de Recherche pour le Developpement
Other Gov
Insecticide Resistance Management in Burkina Faso and Côte D'Ivoire: Research on Vector Control Strategies
Acronym: REACT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05978037
Infections, Malaria
Oxford, Oxfordshire, United Kingdom
View Trial DetailsNCT05891236
Infections, Malaria
Baltimore, Maryland, United States
View Trial DetailsNCT07060508
Infections, Malaria
Faladié, Koulikoro, Mali
View Trial DetailsNCT04529434
Diarrhoea;Acute, Infections
Dar Es Salaam, Mtwara, Tanzania
View Trial Details